Leveraging Technology to Push Forward During a Pandemic
On Demand Webinar

Leveraging Technology to Push Forward During a Pandemic

On Demand Webinar

Automation to Improve Productivity

Leverage Technology to Push Forward During a Pandemic
Leverage Technology to Push Forward During a Pandemic

Since its inception in 2014, Merck's Process Development Intensification Laboratory (iLab) within Small Molecule Process Research & Development has been focused on the development of tools and techniques to enable acquisition of deeper, more fundamental process understanding in a resource sparing manner. This is centered around the concept of data intensification, specifically, around enabling more efficient data capture, data reduction and data analysis. We have grown to call these activities Data-Rich Experimentation (DRE) and investments have spawned a broader strategic initiative, across large and small molecule Process R&D, called "the DRE Initiative".

This presentation highlights the installation of novel, enabling technologies, such as process modeling, bench-top automation, medium and high-throughput experimentation, process analytical technologies (PAT) and statistically designed experimentation. We look back on:

  • The development, demonstration, and the deployment of novel tools designed to increase the information density of the experiments we conduct
  • The efficiency of the chemists and engineers who conduct data rich experimentation (DRE)
  • How enabling technologies were leveraged to continued research efforts during the pandemic

Join the hundreds of researchers who already viewed this presentation.

Shane Grosser, Ph.D. - Merck & Co, Inc.
29 Minutes
English
Shane Grosser, Ph.D. - Merck & Co, Inc.
Shane Grosser, Ph.D. - Merck & Co, Inc.
This page is not optimized for your web browser. Consider using a different browser or upgrade your browser to the latest version to ensure the best experience.